title: Hemolytic uremic syndrome: an unusual complication of interferon-β treatment in a MS patient.
authors.forename: Elodie
authors.initials: E
authors.lastname: Nerrant
authors.forename: Mahmoud
authors.initials: M
authors.lastname: Charif
authors.forename: Anne-Sophie
authors.initials: AS
authors.lastname: Ramay
authors.forename: Hélène
authors.initials: H
authors.lastname: Perrochia
authors.forename: Laure
authors.initials: L
authors.lastname: Patrier
authors.forename: Nicolas Menjot
authors.initials: NM
authors.lastname: de Champfleur
authors.forename: Dimitri
authors.initials: D
authors.lastname: Renard
authors.forename: Pierre
authors.initials: P
authors.lastname: Labauge
mesh_terms: D000276:Adjuvants, Immunologic / Q000009:adverse effects* / Q000627:therapeutic use; D000328:Adult; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000139:chemically induced*; D006801:Humans; D016899:Interferon-beta / Q000009:adverse effects* / Q000627:therapeutic use; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*
chemical_list: D000276:Adjuvants, Immunologic; D016899:Interferon-beta